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A 65-year-old female patient with extensive body tattoos and no medical history of interest, presented at the outpatient 
dermatological clinic, University Hospital San Cecilio, 
Granada, Spain, with a two-week history of several 
rapidly growing crusted nodules on the red tattoo 
ink that had been done one month prior [Figure 1]. 
On clinical examination, several well-demarcated, 
skin-coloured hyperkeratotic nodules with central 
ulcerations and crateriform surfaces, ranging in size 
between 0.4–2 cm on the right leg were discovered. 
No other lesions could be observed. Haematoxylin and 
eosin examination and cultures for bacteria, fungi and 
atypical mycobacteria were made from samples taken 
by cutaneous biopsy. Histological examination showed 
findings compatible with eruptive keratoacanthomas 
(KA) and an intense chronic histiocytic dermatitis in 
response to the exogenous pigments in the underlying 
dermis [Figure 2]. After one week, some of the lesions 
had resolved spontaneously and the largest lesion was 
treated with intralesional methotrexate 15 mg/dL 
every other week, which resulted in a mild decrease in 
size. A complete removal of the lesion was performed, 
with no recurrence after 12-months of follow-up.
Comment
KA is a relatively common keratinising squamous 
neoplasm that only rarely progresses to metastatic 
carcinoma, in spite of its initial rapid growth. This 




Figure 1: Hyperkeratotic nodules appearing on the red ink of a tattoo on the leg of a 65-year-old female patient.
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lesion usually presents as a solitary dome-shaped, skin-
coloured nodule with a central keratinous core, most 
commonly on sun-exposed skin areas of middle-aged 
or elderly people. Involution may occur spontaneously 
after a few months.1
Eruptive KA has been rarely described in the 
literature. Although its origin remains uncertain, 
several factors have been associated with the 
development of these lesions, including ultraviolet 
light exposure, genetic background, carcinogens, 
immunosuppression, viruses and various types of skin 
trauma.2
Kluger and Koljonen reported 50 cases of skin 
cancers on tattoos, 23 of which were squamous 
carcinoma or KA; in a case-series of 8 patients with 
11 tattoo associated KA, 82% of the cases occurred 
in red tattoo ink, which is well known to be the most 
reactive of ink colours.2 This is possibly related to the 
inflammatory nature of its specific components. The 
physiopathology of KA formation remains unclear. It 
has been postulated that KA develops as a result of 
hypersensitivity to the ink or due to trauma or viral 
infection from the tattooing process. Another theory 
postulates that the ink itself may possess carcinogenic 
properties.3 The composition of tattoo inks has not 
been properly regulated and some components 
have been classified by the International Agency 
for Research on Cancer as possibly carcinogenic to 
humans (e.g. mercury, cobalt salts and carbon black) 
or carcinogenic to humans (e.g. cadmium).2 On the 
other hand, some authors consider KA formation 
to be a reactive response rather than a neoplastic 
condition. Junqueira et al. hypothesised that the skin 
tries to eliminate the ink like a foreign body by the 
development of granulomas.4
Differential diagnosis of KA arising within tattoos 
may include mycobacterial or fungal infections, foreign 
body reactions, pseudolymphomatous reactions or 
sarcoidosis. Histological examination should always 
be performed, which is considered the gold standard 
to confirm the diagnosis and rule out squamous cell 
carcinoma.
Multiple treatment modalities have been 
suggested for KA. While spontaneous regression has 
been described; in fact, several small nodules resolved 
spontaneously in our case. For lesions not resolving on 
their own, surgical modalities may be considered as 
the first-line treatments. This includes shave excision, 
curettage, cautery and surgical excision; other 
options include intralesional therapy with steroids, 
methotrexate, 5-fluorouracil (5-FU) or bleomycin and 
topical agents, such as imiquimod or 5-FU. Systemic 
modalities include steroids, methotrexate or retinoids. 
Acitretin, a metabolite of etretinate that inhibits the 
growth of keratinocytes, used in a dose of 25 mg daily 
is the preferred treatment for recalcitrant lesions and 
for patients in whom surgery or radiation therapy can 
cause aesthetic defects.5 Finally, ablative therapies 
such as radiation therapy, laser therapy, cryotherapy 
or photodynamic therapy may be useful, especially for 
small lesions.6
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Figure 2: A: Haematosilin and eosin stain at x10 maginification showing proliferation of atypical keratinocytes with 
crateriform appearance and central corneal material. B: Haematosilin and eosin stained dermis at x20 maginification 
showing intense mixed inflammatory infiltrate predominantly histiocytic and subcutaneous cellular tissue with abundant 
exogenous pigment.
